Form 4 for NEPH NEPHROS INC
Accepted 2024-03-14 00:00:00 ET · period of report 2024-03-12 · accession 0001048462-24-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-14 | 2024-03-12 | NEPH | Amron Arthur H | Dir | P - Purchase | $2.45 | +7,000 | 7,000 | New | +$17.1K | |
| 2024-03-14 | 2024-03-13 | NEPH | Amron Arthur H | Dir | J - Other | $0.00 | +91.5K | 98.5K | +1,307% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2024-03-12 | P | A | 7,000 | $2.45 | 7,000 | D | — | — | (F1) Represents a weighted average price. These shares of common stock were purchased in multiple transactions at prices ranging from $2.3899 to $2.4857, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. |
| 2 | Common | Common stock | 2024-03-13 | J | A | 91,463 | $0.00 | 98,463 | D | — | — |